Tensive S.r.l.

Tensive is a biomedical startup established in 2012 to develop innovative scaffolds aiming to offer a natural breast reconstruction or augmentation. Tensive prostheses are based on biodegradable synthetic biomaterials and fabricated with an internal micro-architecture. REGENERA is not yet commercially available and is undergoing clinical investigation pursuant to regulations for investigational medical devices. Tensive recently completed a First-in-Human study of REGENERA, conducted in Italy in patients diagnosed with benign breast lesion and treated with lumpectomy. Tensive's long-term mission is to restore a natural breast to patients who experienced reconstructive surgery after mastectomy or lumpectomy, to improve their quality of life and avoiding recurrent and expensive surgical operations.